These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 3122200)

  • 21. [An evaluation of the results of the use of a short-duration chemotherapy regimen (3+3) in cases with tuberculosis of the respiratory tract in 1986].
    Didilescu C
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1989; 38(2):173-5. PubMed ID: 2555903
    [No Abstract]   [Full Text] [Related]  

  • 22. The short-course treatment of tuberculosis in Spain.
    Guerra Sanz FJ
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1985; 34(2):141-8. PubMed ID: 2999951
    [No Abstract]   [Full Text] [Related]  

  • 23. [Changes in the number and virulence of tubercle bacilli isolated form pulmonary tuberculosis during short course chemotherapy].
    Chen SH
    Zhonghua Jie He He Hu Xi Za Zhi; 1990 Oct; 13(5):286-8, 318. PubMed ID: 2128212
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Short-course chemotherapy of pulmonary tuberculosis and several problems concerning its use, especially in India].
    Fox W
    Bull Int Union Tuberc; 1985; 60(1-2):44-54. PubMed ID: 3935193
    [No Abstract]   [Full Text] [Related]  

  • 25. [Long-term results of short course chemotherapy of pulmonary tuberculosis. Second study-B: results at 6 years after the end of 4-9 month chemotherapy of pulmonary tuberculosis].
    Baba H; Shinkai A; Izuchi R; Azuma Y
    Kekkaku; 1987 Oct; 62(10):511-20. PubMed ID: 3444194
    [No Abstract]   [Full Text] [Related]  

  • 26. [Approaches to combined therapy of pulmonary tuberculosis in adolescents excreting drug-resistant Mycobacterium tuberculosis].
    Firsova VA; Rusakova LI; Grigor'eva ZP; Ryzhova AP; Iatskova TV; Poluéktova FG
    Probl Tuberk; 2001; (1):28-30. PubMed ID: 11337776
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Bacterial excretion and the bacteriostatic activity of the blood in the chemotherapy of middle-aged and elderly tuberculosis patients].
    Ginzburg TS; Iakimets VP
    Probl Tuberk; 1983 May; (5):57-61. PubMed ID: 6408638
    [No Abstract]   [Full Text] [Related]  

  • 28. [The operational control studies of smear positive tuberculosis cases with short-course chemotherapy under the full-course management and supervision].
    Dai YS; Li Q; Duanmu HJ
    Zhonghua Jie He He Hu Xi Za Zhi; 1994 Oct; 17(5):278-80, 318. PubMed ID: 7712567
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Formation of a filterable form of the causative agent of tuberculosis in the chemotherapy process (an experimental study)].
    Khomenko AK; Golyshevskaia VI; Korolev MB; Drozdov SG
    Probl Tuberk; 1982 Mar; (3):50-4. PubMed ID: 6806805
    [No Abstract]   [Full Text] [Related]  

  • 30. [Chemotherapy of tuberculosis with controlled viability of Mycobacteria in the sputum].
    Rudoĭ NM; Erkovskaia OIu
    Probl Tuberk; 1978 May; (5):43-7. PubMed ID: 97658
    [No Abstract]   [Full Text] [Related]  

  • 31. Short-course treatment in pulmonary tuberculosis.
    East Afr Med J; 1973 Dec; 50(12):672-80. PubMed ID: 4132127
    [No Abstract]   [Full Text] [Related]  

  • 32. [Problems in the treatment of patients with pulmonary tuberculosis].
    Chukanov VI
    Probl Tuberk; 1997; (4):17-9. PubMed ID: 9333807
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tuberculosis chemotherapy--how long.
    Lancet; 1979 Jun; 1(8131):1383-4. PubMed ID: 87838
    [No Abstract]   [Full Text] [Related]  

  • 34. [The relation between bacilli negative conversion rate and the number of combined sensitive antituberculous drugs in intermittent administration of rifampicin for severe pulmonary tuberculosis].
    Tamura M; Yamazaki A; Tamura T; Takano S; Yamazaki M
    Kekkaku; 1973 Jul; 48(7):297-302. PubMed ID: 4200058
    [No Abstract]   [Full Text] [Related]  

  • 35. [Controlled clinical trial on efficacy of 5-month regimens and whole course intermittent 6-month regimens in treating bacillary pulmonary tuberculosis].
    Chu N; Yan B; Zhu L
    Zhonghua Jie He He Hu Xi Za Zhi; 1998 Jul; 21(7):388-91. PubMed ID: 11326873
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Mycobacterium tuberculosis L forms in patients with pulmonary and pleural tuberculosis during antibacterial chemotherapy].
    Osiĭskiĭ IIu; Kotliar KD
    Vrach Delo; 1989 Sep; (9):55-6. PubMed ID: 2514488
    [No Abstract]   [Full Text] [Related]  

  • 37. Bacteriological bases of short-course chemotherapy.
    Grosset J
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1985; 34(2):103-7. PubMed ID: 2999945
    [No Abstract]   [Full Text] [Related]  

  • 38. [Conclusions drawn about the current situation of antitubercular chemotherapy in Romania based on the 1987 national evaluation questionnaire].
    Anastasatu C; Corlan E
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1989; 38(2):157-68. PubMed ID: 2555900
    [No Abstract]   [Full Text] [Related]  

  • 39. [The evaluation of short-duration antitubercular chemotherapy (6 months) in rural areas].
    Serban G; Creţu D
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1989; 38(4):368-71. PubMed ID: 2560252
    [No Abstract]   [Full Text] [Related]  

  • 40. [Should chemotherapy for pulmonary tuberculosis be started after the completion of pretreatment sputum examination?].
    Ito K; Aono A; Yoshiyama T; Wada M; Ogata H
    Kekkaku; 2005 Dec; 80(12):735-41. PubMed ID: 16447786
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.